Title	Publication Date	Language	Citations
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer	2002/05/01	English	490
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer	2008/09/02	English	486
Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water	1992/11/01	English	481
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer	2015/03/31	English	470
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression	2018/11/09	English	463
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis	2003/07/01	English	462
Cancer risk following organ transplantation: a nationwide cohort study in Sweden	2003/09/30	English	460
Psychiatric morbidity and its recognition by doctors in patients with cancer	2001/01/01		460
A prognostic index in primary breast cancer	1982/03/01	English	458
A pooled analysis of magnetic fields and childhood leukaemia	2000/09/01		456
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers	2006/02/21	English	455
Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach	2006/07/11	English	453
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network	2011/11/01	English	450
Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases	2000/11/01		444
Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling	2013/12/12	English	441
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis	2006/08/01	English	436
A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474	1971/06/01	English	432
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours	2020/04/02	English	430
16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010	2011/12/01	English	430
Circulating microRNAs in plasma of patients with gastric cancers	2010/03/01	English	430
Cancer health disparities in racial/ethnic minorities in the United States	2020/09/09	English	428
The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour	1968/06/01	English	421
The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population	2005/09/27	English	421
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres	2010/02/16	English	420
Are cancer cells acidic?	1991/09/01	English	420
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients	2014/10/28	English	415
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis	2004/12/14	English	412
Survival Analysis Part II: Multivariate data analysis – an introduction to concepts and methods	2003/07/29	English	410
Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology	1998/03/01	English	405
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin	2004/10/12	English	402